CLEVELAND BIOLABS INC has a total of 88 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are RHYTHM METABOLIC INC, PEGBIO CO LTD and SYKEHUSET SORLANDET HF.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 15 | |
#2 | United States | 14 | |
#3 | Canada | 6 | |
#4 | China | 6 | |
#5 | EPO (European Patent Office) | 6 | |
#6 | Israel | 5 | |
#7 | Mexico | 5 | |
#8 | Australia | 4 | |
#9 | Brazil | 4 | |
#10 | Hong Kong | 4 | |
#11 | Republic of Korea | 4 | |
#12 | New Zealand | 4 | |
#13 | South Africa | 3 | |
#14 | EAPO (Eurasian Patent Organization) | 2 | |
#15 | Singapore | 2 | |
#16 | Argentina | 1 | |
#17 | Chile | 1 | |
#18 | Colombia | 1 | |
#19 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Measurement | |
#6 | Organic fine chemistry | |
#7 | Machines | |
#8 | Mechanical elements |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Electrotherapy | |
#6 | Analysing materials | |
#7 | Microorganisms | |
#8 | Nails | |
#9 | Unspecified technologies | |
#10 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Gudkov Andrei | 35 |
#2 | Burdelya Lyudmila | 18 |
#3 | Gleiberman Anatoli | 17 |
#4 | Shakhov Alexander N | 17 |
#5 | Gudkov Andrei V | 16 |
#6 | Strom Evguenia | 14 |
#7 | Shakhov Alexander | 14 |
#8 | Fairchild Robert | 9 |
#9 | Mett Vadim | 9 |
#10 | Krivokrysenko Vadim | 9 |
Publication | Filing date | Title |
---|---|---|
WO2016073733A1 | Methods of treating cancer using lipopeptides | |
WO2016109002A2 | Methods and compositions for the treatment of radiation-related disorders | |
WO2016014899A1 | Flagellin derivatives and uses | |
WO2015127227A1 | Uses of flagellin for improved chemotherapy | |
WO2012097012A1 | Use of toll-like receptor agonist for treating cancer | |
CN102170911A | Methods for treating reperfusion injuries | |
WO2009143290A2 | Inducing cell death by inhibiting adaptive heat shock response | |
AU2008204836A1 | Methods for increasing and mobilizing hematopoietic stem cells | |
MY153572A | Methods or protecting against apoptosis using lipopeptides | |
WO2007041497A2 | Modulation of androgen receptor | |
NZ565063A | Methods of protecting against apoptosis using lipopeptides | |
US2006275255A1 | Modulating apoptosis |